SCHEMBL4621

SCHEMBL4621

[CH2]N1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785934 0.96 TTR (0.43)
SCHEMBL3313943 0.87
SCHEMBL7209053 0.79
SCHEMBL1371575 0.73 SMN1; SMN2 (0.44)
SCHEMBL27637444 0.69
SCHEMBL10599432 0.67 MGLL (0.47)
SCHEMBL236146 0.67 MGLL (0.47)
SCHEMBL25928 0.64 TTR (0.50)
SCHEMBL19878897 0.64
SCHEMBL11554965 0.64 TTR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 14849 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029739-B2 SHP2 inhibitor and use thereof KANAPH THERAPEUTICS INC. (KR) 2024-07-09 US claimed
EP-3972589-B1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES MERCK SHARP & DOHME LLC (US) 2024-07-03 EP claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 WO claimed
CN-118239953-A Compounds for the treatment of PI3K gamma mediated diseases and uses thereof 中国科学院合肥物质科学研究院 2024-06-25 CN claimed
US-20240189306-A1 SHP2 INHIBITOR AND USE THEREOF KANAPH THERAPEUTICS INC. (KR) 2024-06-13 US claimed
EP-4373835-A1 MACROCYLIC IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2024-05-29 EP claimed
CN-115335431-B Modified poly (phenylene ether) copolymers, compositions and methods 高新特殊工程塑料全球技术有限公司 2024-05-24 CN claimed
WO-2024104425-A1 KRAS INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业股份有限公司 2024-05-23 WO claimed
EP-3702354-B1 COMPOUND HAVING ERK KINASE INHIBITORY ACTIVITY AND USE THEREOF HAIHE BIOPHARMA CO LTD (CN) 2024-05-22 EP claimed
EP-3468953-B1 SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 GLAXOSMITHKLINE IP DEV LTD (GB) 2024-05-22 EP claimed
US-4379924-A Cephalosporin derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1983-04-12 US claimed
EP-0062834-A1 Thiocarbamic-acid esters, process for their preparation, medicines containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1982-10-20 EP claimed
EP-0042593-A1 Aryloxy-propanol amines, process for their preparation and medicines containing these compounds Roche Diagnostics GmbH (DE) 1981-12-30 EP claimed
US-4256830-A SUBSTITUTED ALKYNES, ANTIFOGGING AGFA-GEVAERT, A.G. (DE) 1981-03-17 US claimed
US-4183927-A Substituted phenylthioalkylamines and compositions thereof THE DOW CHEMICAL COMPANY (US) 1980-01-15 US claimed
US-4155907-A Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines THE DOW CHEMICAL COMPANY (US) 1979-05-22 US claimed
US-4137315-A ANTIMICROBIAL, ANTIFUNGAL, ANTISEPTICS RHONE-POULENC INDUSTRIES (FR) 1979-01-30 US claimed
US-3994891-A VASODILATORS ARMOUR PHARMACEUTICAL COMPANY (US) 1976-11-30 US claimed
US-3956297-A 9H-Dibenzo[b,f]imidazo[1,2-d][1,4]diazepines THE UPJOHN COMPANY (US) 1976-05-11 US claimed
US-3950522-A N-ALKENYL OR N-ALKYNYL THIOAMIDES SMITHKLINE CORPORATION (US) 1976-04-13 US claimed